triazoles has been researched along with Hemosiderosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chirnomas, D; Esposito, J; Giardina, PJ; Goldberg, SL; Paley, C; Vichinsky, E | 1 |
| Adamaki, M; Athanasiadou, A; Ktena, YP; Lambrou, G; Moschovi, M | 1 |
| Alam, MH; Carpenter, JP; Garbowski, MW; He, T; Pennell, DJ; Porter, JB; Roughton, M; Smith, G | 1 |
| Cappellini, MD; Castiglioni, C; Longo, F; Origa, R; Piga, A; Pinna, F; Roggero, S; Zappu, A | 1 |
| Al Zoebie, A; Bruederle, A; Chotsampancharoen, T; El-Beshlawy, A; Elalfy, M; Gilotti, G; Han, J; Kamdem, A; Koussa, S; Vichinsky, E | 1 |
| Bagust, A; Boland, A; Chu, P; Dickson, R; Dundar, Y; Fleeman, N; Greenhalgh, J; Kirkham, J; McLeod, C; Modell, B; Olujohungbe, A; Telfer, P; Walley, T | 1 |
| Agarwal, MB | 1 |
| Brown, GC; Patton, WN; St Pierre, TG; Tapp, HE; Taylor, DJ | 1 |
| Galanello, R | 1 |
| Al-Fayoumi, S; Castillo, S; Chakraborti, T; Choudary, J; Frankewich, R; Kacuba, A; Pazdur, R; Rieves, D; Robie-Suh, K; Shashaty, G; Weiss, K | 1 |
| Stumpf, JL | 1 |
| Vichinsky, E | 1 |
| Abetz, L; Baladi, JF; Coates, T; Coïc, L; Files, B; Fischer, R; Forni, GL; Lane, P; Marks, P; Mueller, BU; Onyekwere, O; Pakbaz, Z; Porter, J; Rofail, D; Swerdlow, P; Vichinsky, E | 1 |
4 review(s) available for triazoles and Hemosiderosis
| Article | Year |
|---|---|
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.
Topics: Anemia; Benzoates; Chronic Disease; Contraindications; Cost-Benefit Analysis; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemosiderosis; Humans; Iron Chelating Agents; Pyridones; Randomized Controlled Trials as Topic; Technology Assessment, Biomedical; Transfusion Reaction; Treatment Outcome; Triazoles | 2009 |
Deferasirox: oral, once daily iron chelator--an expert opinion.
Topics: Benzoates; Cardiovascular Diseases; Chelating Agents; Deferasirox; Expert Testimony; Hemosiderosis; Humans; Iron; Liver; Thalassemia; Triazoles | 2010 |
Deferasirox.
Topics: Adult; Benzoates; Child; Deferasirox; Deferoxamine; Hematologic Diseases; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Patient Compliance; Siderophores; Transfusion Reaction; Triazoles | 2007 |
Clinical application of deferasirox: practical patient management.
Topics: Administration, Oral; Adult; Benzoates; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Contraindications; Creatinine; Deferasirox; Disease Management; Drug Eruptions; Gastrointestinal Diseases; Hematologic Diseases; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Transfusion Reaction; Triazoles | 2008 |
6 trial(s) available for triazoles and Hemosiderosis
| Article | Year |
|---|---|
The palatability and tolerability of deferasirox taken with different beverages or foods.
Topics: Adolescent; Benzoates; Beverages; Blood Transfusion; Child; Child, Preschool; Deferasirox; Female; Food; Food-Drug Interactions; Hematologic Diseases; Hemosiderosis; Humans; Iron Chelating Agents; Male; Triazoles | 2013 |
Iron chelation with deferasirox for the treatment of secondary hemosiderosis in pediatric oncology patients: a single-center experience.
Topics: Adolescent; Benzoates; Chelation Therapy; Child; Child, Preschool; Deferasirox; Female; Ferritins; Hemosiderosis; Humans; Infant; Iron; Iron Chelating Agents; Male; Neoplasms; Transfusion Reaction; Triazoles; Young Adult | 2013 |
Deferasirox for cardiac siderosis in β-thalassaemia major: a multicentre, open label, prospective study.
Topics: Adult; Benzoates; beta-Thalassemia; Cardiomyopathies; Chelation Therapy; Deferasirox; Female; Ferritins; Hemosiderosis; Humans; Iron Chelating Agents; Liver; Magnetic Resonance Imaging; Male; Medication Adherence; Prospective Studies; Stroke Volume; Transfusion Reaction; Triazoles; Young Adult | 2014 |
Evaluation of ICL670, a once-daily oral iron chelator in a phase III clinical trial of beta-thalassemia patients with transfusional iron overload.
Topics: Administration, Oral; Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Child; Deferasirox; Dose-Response Relationship, Drug; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Transfusion Reaction; Treatment Outcome; Triazoles | 2005 |
Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Blood Transfusion; Child; Child, Preschool; Deferasirox; Deferoxamine; Female; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Siderophores; Triazoles | 2006 |
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.
Topics: Absenteeism; Adolescent; Adult; Anemia, Sickle Cell; Benzoates; Chelation Therapy; Child; Child, Preschool; Deferasirox; Deferoxamine; Female; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Male; Middle Aged; Patient Satisfaction; Surveys and Questionnaires; Transfusion Reaction; Treatment Outcome; Triazoles | 2008 |
3 other study(ies) available for triazoles and Hemosiderosis
| Article | Year |
|---|---|
Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan.
Topics: Algorithms; Benzoates; Biomarkers; Biopsy; Calibration; Deferasirox; Hemosiderosis; Humans; Image Interpretation, Computer-Assisted; Iron; Iron Chelating Agents; Least-Squares Analysis; Linear Models; Liver; Magnetic Resonance Imaging; Observer Variation; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Transfusion Reaction; Triazoles | 2014 |
Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST).
Topics: Benzoates; Chelation Therapy; Child, Preschool; Deferasirox; Female; Hematologic Diseases; Hemosiderosis; Humans; Iron Chelating Agents; Male; Transfusion Reaction; Triazoles | 2017 |
Spin density projection-assisted R2 magnetic resonance imaging of the liver in the management of body iron stores in patients receiving multiple red blood cell transfusions: an audit and retrospective study in South Australia.
Topics: Adolescent; Adult; Aged; Benzoates; Chelation Therapy; Child; Deferasirox; Deferoxamine; Erythrocyte Transfusion; Female; Ferritins; Hematologic Diseases; Hemosiderosis; Humans; Infant; Infusions, Intravenous; Injections, Subcutaneous; Iron; Iron Chelating Agents; Liver; Magnetic Resonance Imaging; Male; Medical Audit; Middle Aged; Retrospective Studies; ROC Curve; Sensitivity and Specificity; South Australia; Triazoles | 2012 |